Dabigatran Etexilate: Oral Direct Thrombin Inhibition

2026-09-22

Prestained Protein Marker: Triple-Color Workflow

2026-09-22

This guide explains how to use the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) as a visible size reference and qualitative transfer check in SDS-PAGE and Western blot workflows. It is appropriate for Phosbind SDS-PAGE and fluorescent membrane imaging, but it should not be treated as a quantitative protein calibrant or a substitute for an unstained standard when dye-free detection is required.

Nurr1+ Neurons and Rat Claustrum Development

2026-09-21

Fang, Wang, and Naumann mapped the developmental appearance and embryonic birth timing of Nurr1-positive neurons across the rat claustrum, endopiriform region, and lateral cortex. By combining EdU birth dating with Nurr1 in situ hybridization, the study resolves subregional neurogenetic gradients and provides a framework for interpreting claustral organization during development.

Intravitreal Metformin in CNV and Retinal Degeneration

2026-09-21

This preclinical study shows that intravitreal metformin can suppress choroidal neovascularization, reduce inflammatory-cell infiltration, and limit light-induced retinal thinning in mouse models. Its main contribution is the parallel evaluation of anti-angiogenic and neuroprotective effects, while also identifying inflammation- and angiogenesis-associated gene responses that warrant further translational study.

Deep Learning for iPSC-CM Cardiotoxicity Screening

2026-09-20

Grafton et al. developed a high-content imaging and deep-learning workflow that assigns a single cardiotoxicity score to compounds tested in human iPSC-derived cardiomyocytes. The study shows how phenotype-first analysis can identify diverse liability classes early in drug discovery and guide follow-up testing before late-stage development.

VX-661: F508del CFTR Corrector Guide

2026-09-19

VX-661 is a F508del CFTR corrector that improves folding, trafficking, and cell-surface expression of defective CFTR in experimental systems. Its activity is context-dependent: variant identity, calnexin-dependent proteostasis, exposure conditions, and combination with VX-770 can change the measured rescue.

HyperScript™ Reverse Transcriptase for qPCR

2026-09-18

Learn how HyperScript™ Reverse Transcriptase (SKU K1071) can support RNA-to-cDNA conversion when cell viability, proliferation, or cytotoxicity studies generate limited or structurally complex RNA. This scenario-based guide separates product-supported capabilities from workflow recommendations for more defensible qPCR interpretation.

2'-O-Methyladenosine: Assay Workflow Guide

2026-09-18

Build more reliable nucleoside transport, RNA modification, and purine metabolomics experiments with 2'-O-Methyladenosine. This guide translates a high-sensitivity UHPLC–MS/MS workflow into practical preparation, extraction, assay, and troubleshooting decisions.

Nigericin as a Causal Probe of Ion–Metabolism Coupling

2026-09-17

Nigericin is a potassium/hydrogen ion carrier that converts membrane-gradient disruption into a measurable biological perturbation. This article connects intracellular pH modulation and mitochondrial ion transport with metabolism-aware assay design, while clarifying what recent antibiotic-resistance research does—and does not—demonstrate.

Nullscript: Reliable HDAC Assay Design

2026-09-17

This scenario-driven guide explains how Nullscript (SKU C3606) can support reproducible HDAC, viability, proliferation, and cytotoxicity workflows. It covers assay compatibility, stock preparation, interpretation of transcriptional inactivity, cardiac ischemia/reperfusion relevance, and practical product-selection criteria.

LNP-mRNA Fibroblasts for Intervertebral Disc Degeneration

2026-09-16

The reference study develops fibroblasts engineered with lipid nanoparticle-delivered mRNA to produce TNF-α-neutralizing antibodies within the degenerative disc environment. In inflammatory and rat intervertebral disc degeneration models, the engineered cells outperformed naive fibroblasts by preserving cell function, reducing inflammatory signaling, restoring extracellular matrix production, and improving disc height.

HyperScript™ Reverse Transcriptase for Adipose qPCR

2026-09-16

HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when adipose-tissue transcripts are scarce or structurally challenging. This article connects enzyme selection with the interpretation of Netrin-1, PPARγ, and Wnt/β-catenin expression assays in obesity research.

Lysoptosis: A Conserved Serpin-Regulated Death Pathway

2026-09-15

The reference study defines lysoptosis as an evolutionarily conserved lysosome-dependent cell death pathway in which lysosomal membrane permeabilization and cathepsin release drive cellular demise when intracellular serpins are absent. Its cross-species genetic and cell-biological evidence separates lysoptosis from incidental lysosomal damage associated with other regulated cell death programs.

PF-562271 HCl for FAK/Pyk2 Cancer Research

2026-09-15

PF-562271 HCl enables controlled interrogation of FAK/Pyk2 signaling in tumor-cell, stromal, and immune-cell assays. Its reversible, ATP-competitive profile complements radiotherapy and checkpoint-blockade models by linking pathway inhibition with tumor growth, metastasis, and immune-response measurements.

Budesonide B1900: Reliable Cell Assays

2026-09-14

This scenario-driven guide shows how Budesonide SKU B1900 can improve interpretation of viability, proliferation, cytotoxicity, and airway-inflammation experiments. It connects formulation data with pulmonary permeability evidence and practical controls for reproducible laboratory workflows.